Evado signs distribution deal
Monday, 14 April, 2008
Specialist life science training, quality assurance and regulatory compliance company SeerPharma has signed a re-seller agreement with Evado, a division of Australian company Invision IT Systems.
SeerPharma will distribute Evado's new web-based enterprise pre-clinical, clinical and mobile software modules in the SE Asian region. SeerPharma will also offer Evado as a software-as-a-service (SaaS) application to its medical device, biotechnology and life science clients.
Evado is a form-based technology that replaces the paper-based case report forms with easy to customise templates that are suitable for drug or device trials.
"Evado was created to provide a simple, easy-to-use, economical alternative to expensive clinical trial software," Evado's CEO Jennie Anderson said.
"Evado helps speed up clinical trials and assists researchers in the development of new medical therapies and medical devices by reducing costs and by improving data accuracy thereby achieving quicker regulatory approvals and time to market."
Scientists find new driver of ovarian cancer spread
A cell surface receptor known as F2R could serve as both a diagnostic marker for ovarian cancer...
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...
Targeting 'molecular bodyguards' weakens prostate cancer cells
Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...
